Insomnia drugs: Zopiclone, Zolpidem and Nitrazepam boxes with fewer tablets for better use

News Healthcare & Pharma Sanctions & Fines

Date: 30th Jun, 2025 Source: French National Agency for the Safety of Medicines and Health Products (ANSM) Country: France Original Source

Brief

On 30/06/2025, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding Insomnia drugs: Zopiclone, Zolpidem and Nitrazepam boxes with fewer tablets for better use. The agency requested manufacturers to provide smaller packaging options containing 5-7 tablets, aligning with a one-week treatment duration, to reduce the risk of prolonged use and dependence on these benzodiazepines.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Insomnia drugs: Zopiclone, Zolpidem and Nitrazepam boxes with fewer tablets for better use

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Insomnia drugs: Zopiclone, Zolpidem and Nitrazepam boxes with fewer tablets for better use

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.